291 related articles for article (PubMed ID: 38014626)
1. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
Wen KY; Dayaratna S; Slamon R; Granda-Cameron C; Tagai EK; Kohler RE; Hudson SV; Miller SM
Transl Behav Med; 2024 Jan; 14(1):1-12. PubMed ID: 38014626
[TBL] [Abstract][Full Text] [Related]
2. Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.
Kulkarni A; Glynn S; Gamble CR; Shen MJ; Cantillo E; Frey MK; Holcomb KM; Safford MM; Chapman-Davis E
J Low Genit Tract Dis; 2023 Jan; 27(1):87-92. PubMed ID: 36074132
[TBL] [Abstract][Full Text] [Related]
3. Development of a text message-based intervention for follow-up colposcopy among predominately underserved Black and Hispanic/Latinx women.
Sansoni M; Tagai EK; Lapitan E; Wen KY; Xu J; Belfiglio A; Hudson SV; Kohler RE; Hernandez E; Miller SM
Cancer Causes Control; 2022 Jun; 33(6):861-873. PubMed ID: 35334016
[TBL] [Abstract][Full Text] [Related]
4. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
[TBL] [Abstract][Full Text] [Related]
5. Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy.
Percac-Lima S; Aldrich LS; Gamba GB; Bearse AM; Atlas SJ
J Gen Intern Med; 2010 Nov; 25(11):1198-204. PubMed ID: 20652647
[TBL] [Abstract][Full Text] [Related]
6. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.
Miller SM; Siejak KK; Schroeder CM; Lerman C; Hernandez E; Helm CW
J Natl Cancer Inst; 1997 May; 89(10):703-8. PubMed ID: 9168185
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.
Hui SK; Miller SM; Wen KY; Fang Z; Li T; Buzaglo J; Hernandez E
J Prim Care Community Health; 2014 Oct; 5(4):234-41. PubMed ID: 24718518
[TBL] [Abstract][Full Text] [Related]
8. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Use of Short Messaging Service to Improve Follow-Up for Abnormal Pap Test Results in Minority and Medically Underserved Women in North Carolina: Questionnaire on Attitudes and Acceptability.
Romocki LS; Des Marais A; Cofie L; Anderson C; Curington T; Smith JS
JMIR Form Res; 2019 Aug; 3(3):e12675. PubMed ID: 31389334
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
[TBL] [Abstract][Full Text] [Related]
12. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
13. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
14. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
15. Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women.
Miller SM; Hui SK; Wen KY; Scarpato J; Zhu F; Buzaglo J; Hernandez EE
Patient Educ Couns; 2013 Dec; 93(3):488-95. PubMed ID: 24007767
[TBL] [Abstract][Full Text] [Related]
16. Women's experiences in coping with abnormal Papanicolaou results and follow-up colposcopy.
Lauver DR; Baggot A; Kruse K
J Obstet Gynecol Neonatal Nurs; 1999; 28(3):283-90. PubMed ID: 10363540
[TBL] [Abstract][Full Text] [Related]
17. Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention.
Lee HY; Koopmeiners JS; Rhee TG; Raveis VH; Ahluwalia JS
J Med Internet Res; 2014 Aug; 16(8):e196. PubMed ID: 25164545
[TBL] [Abstract][Full Text] [Related]
18. Addressing Unmet Basic Needs to Improve Colposcopy Adherence Among Women With Abnormal Cervical Cancer Screening.
Kuroki L; Massad LS; Martin A; Liu J; Brown D; Leon A; Groesch K; Wilson T; Zeino Y; Diaz-Sylvester P; Delfino K; Hyon K; Kreuter M
J Low Genit Tract Dis; 2021 Apr; 25(2):106-112. PubMed ID: 33631781
[TBL] [Abstract][Full Text] [Related]
19. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
20. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
